Navigation Links
MimiVax presenting at Biotech Showcase; Attending JP Morgan 2017 Healthcare Conference

MimiVax to present at Biotech Showcase; attending JP Morgan 2017 Healthcare Conference

MimiVax, LLC will be presenting at the 9th Annual Biotech Showcase Conference in San Francisco, Jan 9-12, 2017. The company will provide an overview and update on its immuno-oncology programs. Company will be highlighting its lead program SurVaxM that is in ongoing Phase II clinical study in patients with newly diagnosed glioblastoma. Besides its late stage SurVaxM program, company will share for the first time its preclinical pipeline of assets. This includes monoclonal antibody (Sur-MAb) and CAR-T/Adaptive T-cell therapy program. The 9th Annual Biotech Showcase Conference presentation will be on Tuesday January 10th at 10:15AM, at the Hilton San Francisco.

MimiVax will also be in attendance for The J.P. Morgan 35th Annual Healthcare Conference, taking place between Jan. 9 – 13, 2017 at the Westin St. Francis Hotel. During the event, MimiVax executives (CSO; Michael Ciesielski, PhD and VP, BD; Anil Goyal, PhD) will be available for meetings to discuss investment and pharmaceutical partnership opportunities.

2017 Biotech Showcase Conference:
Presenting, Tuesday, Jan. 10, 2017, 10:15 AM;
Hilton San Francisco Union Square, Room 9 Ballroom Level, San Francisco, CA

JP Morgan 2017 Healthcare Conference:
Monday - Friday, Jan. 9 - 13, 2017; Westin St. Francis Hotel, San Francisco, CA

About MimiVax: MimiVax is a privately held, clinical-stage biotechnology company focused on the development and commercialization of immunotherapeutics and targeted therapies for the treatment of cancer. Our proprietary product portfolio is based on technology licensed from Roswell Park Cancer Institute that targets survivin, a cell-survival protein that is present in most cancers and rarely detectable in normal tissue. Our therapies are designed to stimulate immune responses to control tumor growth and recurrence.

About SurVaxM: SurVaxM, our lead immunotherapeutic candidate, has demonstrated safety and tolerability and strong efficacy signal in a Phase I study in patients with malignant gliomas (brain tumors). SurVaxM is an “engineered immune activating novel/neo antigen” applicable across most histologies. SurVaxM’s single long peptide (SLP) is engineered to be activating to mid-affinity T cell receptors. Mid-affinity T cell receptors have been shown to be critical for sustained T effector activation and durable T cell responses.   

SurVaxM is currently being evaluated in a Phase II clinical trial in adults with newly diagnosed glioblastoma, and a Phase I clinical trial in combination with REVLIMID® (lenalidomide) as a maintenance therapy for adults with multiple myeloma (a form of blood cancer).

Read the full story at

Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved

Related medicine news :

1. 2017 iaedp™ Symposium Continues Tradition of Presenting the Latest in Eating Disorder Treatment with Top Professionals in U.S.
2. Presenting Channeled Messages for Higher Spiritual Awareness
3. HRA - Healthcare Research & Analytics Executives Presenting at PBIRG 55th Annual General Meeting
4. Florida Hospital Clinches the Presenting Sponsor of the 2016 Tampa Bay Lightning Playoffs and Stanley Cup Finals for the Second Year in a Row
5. Christian Bogner, MD Presenting At The Holistic Cannabis Summit
6. The Oncology Institute of Hope & Innovation Partners with Wellpoint and Stanford in Presenting a Tri-Part Research Collaboration at the 2016 ASCO Quality Care Symposium
7. Clearshark Named Presenting Sponsor of 2016 Iron Girl Columbia Triathlon
8. Four-Week Countdown: 2016 iaedp™ Symposium Continues Tradition of Presenting the Latest in Eating Disorder Treatment with the Country’s Top Professionals
9. Dr. Zaidan Presenting An Educational Seminar On Endometriosis
10. Care Logistics Presenting at the Conference of Metropolitan & Regional Hospital Associations Annual Meeting
11. NATA and the PATS Join Congressman Ryan Costello in Presenting the NATA Safe Sports School Award to Spring-Ford High School
Post Your Comments:
(Date:2/13/2019)... ... , ... Infertility is an issue for 1 in 6 couples; in about 50% of these ... sharp decline in male sperm count over the last 40 years was featured in articles ... panic that we are in the midst of a severe, perhaps irreversible, male infertility crisis. ...
(Date:2/13/2019)... ... February 13, 2019 , ... A Place at Home has received ... Pulse. The Employer of Choice Award is granted only to the top-ranking home care ... research firm for home care. A Place at Home is ranked among the best ...
(Date:2/13/2019)... Calif. (PRWEB) , ... February 13, 2019 , ... Asana ... scholarship. Open to students who choose to pursue a medical-related course of study in ... their passion for substance abuse disorder and mental health treatment, and how it has ...
(Date:2/13/2019)... SANTA MONICA, Calif. (PRWEB) , ... February 13, ... ... Surgeon of Southern California has joined the esteemed Haute Beauty network. , ... is privileged to present Dr. Christie as a leading Aesthetic surgeon and our ...
(Date:2/12/2019)... ... February 12, 2019 , ... A technology company that aims ... visit, won the top award at the 9th annual SPIE Startup Challenge at ... winning pitch, nabbing a combined first prize of $15,000. Radiance 4D’s revolutionary 3D ...
Breaking Medicine News(10 mins):
(Date:2/13/2019)... ... February 13, 2019 , ... ... population health reporting solutions, is launching IMAT 8.0, its latest health data platform, ... a more streamlined user interface and dynamic single-query builder, IMAT 8.0 allows HIEs, ...
(Date:2/13/2019)... ... February 13, 2019 , ... Abu ... Public Private Partnership (PPP) between the Department of Health-Abu Dhabi (DoH) and Injazat ... Health Information Exchange system (HIE), a centralized platform to streamline healthcare connectivity for ...
(Date:2/13/2019)... ... February 13, 2019 , ... Co-founded in a parking lot by ... women an empowering place to not only exercise, but to nurture their mental and ... a former professional baseball player with the San Francisco Giants and COO Morgan brings ...
Breaking Medicine Technology: